Yahoo Web Search

  1. Immunopathological mechanisms in dengue and dengue ...

    journals.lww.com/co-infectiousdiseases/Abstract/...

    e-mediated process. Recent findings Significant findings in the past year include a greater understanding of dengue virus interactions with target cells such as dendritic cells, hepatocytes and endothelial cells. Infection of these cells results in the production of immune mediators that then shape the adaptive humoral and cellular immune response. The circulation of high levels of secreted ...

  2. Role of cognitive parameters in dengue hemorrhagic fever and ...

    www.ncbi.nlm.nih.gov/pmc/articles/PMC4174897

    The exact mechanism by which dengue virus induces plasma leakage or disease severity remains poorly understood. A large majority of the dengue infections occur in humans without any noticeable illness.

    • Jih Jin Tsai, Kulkanya Chokephaibulkit, Po Chih Chen, Po Chih Chen, Li Teh Liu, Hui Mien Hsiao, Yu C...
    • 9
    • 2013
  3. Dengue | CDC

    www.cdc.gov/dengue

    Dengue viruses are spread to people through the bite of an infected Aedes species (Ae. aegypti or Ae. albopictus) mosquito. Dengue is common in more than 100 countries around the world. Forty percent of the world’s population, about 3 billion people, live in areas with a risk of dengue. Dengue is often a leading cause of illness in areas with ...

  4. Mechanism of dengue virus entry into cells revealed

    phys.org/news/2014-02-mechanism-dengue-virus...

    Dengue fever, an infectious tropical disease caused by a mosquito-borne virus, afflicts millions of people each year, causing fever, headache, muscle and joint pains and a characteristic skin rash.

  5. People also ask

    Is dengue vector borne disease?

    What causes Dengue virus?

    What is dengue fever?

    How are dengue viruses spread?

  6. Mechanism of Dengue Virus Entry into Cells

    globalbiodefense.com/2014/02/26/mechanism-of...

    Feb 26, 2014 · Mechanism of Dengue Virus Entry into Cells by Global Biodefense Staff February 26, 2014, 2:48 pm Dengue fever, an infectious tropical disease caused by a mosquito-borne virus, afflicts millions of people each year, causing fever, headache, muscle and joint pains and a characteristic skin rash.

  7. Dengue fever - Symptoms and causes - Mayo Clinic

    www.mayoclinic.org/diseases-conditions/dengue...
    • Overview
    • Symptoms
    • Causes
    • Risk Factors
    • Complications
    • Prevention

    Dengue (DENG-gey) fever is a mosquito-borne disease that occurs in tropical and subtropical areas of the world. Mild dengue fever causes a high fever, rash, and muscle and joint pain. A severe form of dengue fever, also called dengue hemorrhagic fever, can cause severe bleeding, a sudden drop in blood pressure (shock) and death.Millions of cases of dengue infection occur worldwide each year. Dengue fever is most common in Southeast Asia and the western Pacific islands, but the disease has bee...

    Many people, especially children and teens, may experience no signs or symptoms during a mild case of dengue fever. When symptoms do occur, they usually begin four to seven days after you are bitten by an infected mosquito.Dengue fever causes a high fever — 104 F degrees — and at least two of the following symptoms: 1. Headache 2. Muscle, bone and joint pain 3. Nausea 4. Vomiting 5. Pain behind the eyes 6. Swollen glands 7. RashMost people recover within a week or so. In some cases, symptoms...

    Dengue fever is caused by any one of four types of dengue viruses spread by mosquitoes that thrive in and near human lodgings. When a mosquito bites a person infected with a dengue virus, the virus enters the mosquito. When the infected mosquito then bites another person, the virus enters that person's bloodstream.After you've recovered from dengue fever, you have immunity to the type of virus that infected you — but not to the other three dengue fever virus types. The risk of developing seve...

    Factors that put you at greater risk of developing dengue fever or a more severe form of the disease include: 1. Living or traveling in tropical areas. Being in tropical and subtropical areas increases your risk of exposure to the virus that causes dengue fever. Especially high-risk areas are Southeast Asia, the western Pacific islands, Latin America and the Caribbean. 2. Prior infection with a dengue fever virus. Previous infection with a dengue fever virus increases your risk of having seve...

    If severe, dengue fever can damage the lungs, liver or heart. Blood pressure can drop to dangerous levels, causing shock and, in some cases, death.

    One dengue fever vaccine, Dengvaxia, is currently approved for use in those ages 9 to 45 who live in areas with a high incidence of dengue fever. The vaccine is given in three doses over the course of 12 months. Dengvaxia prevents dengue infections slightly more than half the time.The vaccine is approved only for older children because younger vaccinated children appear to be at increased risk of severe dengue fever and hospitalization two years after receiving the vaccine.The World Health Or...

  8. Dec 13, 2018 · Novel mechanisms of dengue and Zika virus infections and link to microcephaly Date: December 13, 2018 Source: Baylor College of Medicine Summary: New insights into how dengue and Zika viruses ...

  9. Natural History of Dengue Virus (DENV)—1 and DENV—4 ...

    academic.oup.com/jid/article/195/7/1007/800572
    • Abstract
    • Methods
    • Results
    • Discussion

    Dengue fever (DF) is a vectorborne disease caused by 4 closely related dengue viruses (DENV 1–4) [1, 2]. DF is distributed in most tropical and subtropical areas, where Aedes aegypti and/or A. albopictus are abundant [3]. Infection with DENV can also cause dengue hemorrhagic fever (DHF), a syndrome characterized by increased vascular permeability, plasma leakage, hypovolemia, and shock [4, 5]. Although the pathogenesis of DHF is not fully understood, several risks have been reported: secondary infection with heterologous strains [6, 7], primary infection in infants born to dengueimmune mothers [8], differing virulence of the strain [9], and differing human susceptibility according to race or genetic factors [10, 11]. Because DENV infections are often clinically inapparent, it is difficult to clarify the epidemiology of DF and dengue pathophysiology without virological support [12, 13]. The natural history of DF involves the time from infection to onset and recovery from disease. How...

    Brief historical background. Both dengue studies were performed in the Philippines and involved large numbers of human volunteers recruited from US Army personnel. The first study, conducted by Joseph Franklin Siler, MiltonWeston Hall, and Arthur Parker Hitchens took place in 1924–1925, whereas the latter was organized by James Stevens Simmons, Joseph Harold St. John, and Francois Hiie Kari Reynolds in 1929–1930 (the latter study is available at: http://plaza.umin.ac.ip/infepi/simmons1.pdf). Both studies were originally published in the Philippine Journal of Science [23, 24] and were reprinted with appendices by the Bureau of Printing, Manila [25, 26]. In 1971–1972, Halstead obtained blood samples from 4 and 5 volunteers involved in each study and demonstrated specific neutralizing antibodies to DENV-4 and DENV-1, respectively [27]. Following these experimental studies of dengue, J. F. Siler (1875–1960) reported the efficacy of antityphoid vaccines [28], whereas J. S. Simmons (1890–...

    Descriptive characteristics. Among those who developed clinically apparent DF, mean ± SD ages were 22.5 ± 4.0 and 22.0 ± 3.4 years in the DENV-4 and DENV-1 studies, respectively. Age was not significantly different between studies (P = .97). The mean ± SD durations of fever were 3.6 ± 1.2 and 4.8 ± 1.2 days, respectively. The febrile period of DENV-1 infection was significantly longer than that of DENV-4 (P < .01). In the DENV-1 study, the mean ± SD values for minimum WBC count and duration of leukopenia were 3.01 × 109 ± 0.78 × 109cells/L and 6.1 ± 2.0 days, respectively, and 37.5% (95% CI, 27.7%–48.5%) and 68.8% (95% CI, 57.9%–77.8%) of diseased individuals exhibited a primary or secondary rash, respectively. Distributions of the intrinsic incubation period are shown in figure 1. The mean ± SD values were 6.0 ± 1.4 days (95% CI, 5.6–6.4 days) and 5.7 ± 1.5 days (95% CI, 5.3–6.0 days) in the DENV-4 and DENV-1 studies, respectively, yielding maximum likelihood estimates of the scale...

    This study examined several aspects of the natural history of DF based on 2 rigorous historical experiments. These studies are unique in that the experimental details for primary DENV infection were provided and because the etiology was known [27]. These records are the most comprehensive of their kind with regard to the intrinsic and extrinsic incubation and infectious periods. Moreover, it was possible for us to compare signs and symptoms as well as other epidemiologic parameters between serotypes. Three findings were notable. First, this study is the first, to our knowledge, to characterize statistical details of the incubation period of DF. Usually, it is extremely difficult to identify the time of infection for vectorborne diseases. For this reason, the incubation period is conveniently extrapolated from experimental inoculation data, travel histories of cases, or incidence data during the point source outbreak, which offers the time of exposure [33]. Similar data to ours (i.e....

  10. Dengue - The Lancet

    www.thelancet.com/journals/lancet/article/PIIS...

    Mortality from severe dengue is low, but the economic and resource burden on health services remains substantial in endemic settings. Unfortunately, progress towards development of effective therapeutics has been slow, despite notable advances in the understanding of disease pathogenesis and considerable investment in antiviral drug discovery.

  11. People also search for